We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+8.99%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$21.9B
AUM Growth
+$21.9B
Cap. Flow
-$417M
Cap. Flow %
-1.9%
Top 10 Hldgs %
13.08%
Holding
3,337
New
135
Increased
1,103
Reduced
1,007
Closed
163

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$89.3M
2
KEYS icon
Keysight
KEYS
+$86M
3
NKE icon
Nike
NKE
+$78.3M
4
APH icon
Amphenol
APH
+$76.5M
5
CMCSA icon
Comcast
CMCSA
+$72.3M

Top Sells

Rank Stock Value
1
CE icon
Celanese
CE
+$108M
2
MNST icon
Monster Beverage
MNST
+$97.8M
3
SBUX icon
Starbucks
SBUX
+$79.7M
4
TXN icon
Texas Instruments
TXN
+$67.3M
5
CNC icon
Centene
CNC
+$64.3M

Sector Composition

Rank Sector Weight
1 Technology 18.83%
2 Financials 13.42%
3 Healthcare 13.25%
4 Industrials 9.77%
5 Consumer Discretionary 7.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HTO
2151
H2O America
HTO
$2.69B
$6K ﹤0.01%
89
– –
SNV
2152
DELISTED
Synovus
SNV
$6K ﹤0.01%
162
+160
+8,000% +$5.88K
NBIS
2153
Nebius Group N.V.
NBIS
$43.1B
$6K ﹤0.01%
140
+126
+900% +$4.7K
NPKI
2154
NPK International
NPKI
$1.09B
$6K ﹤0.01%
1,068
– –
LGF.B
2155
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
$6K ﹤0.01%
678
– –
BBBY
2156
DELISTED
Bed Bath & Beyond Inc
BBBY
$6K ﹤0.01%
391
-15
-4% -$210
FSTX
2157
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
$6K ﹤0.01%
1,042
– –
ENDP
2158
DELISTED
Endo International plc
ENDP
$6K ﹤0.01%
1,400
+594
+74% +$2.65K
BMTC
2159
DELISTED
Bryn Mawr Bank Corp
BMTC
$6K ﹤0.01%
155
+105
+210% +$4.05K
AEGN
2160
DELISTED
Aegion Corp
AEGN
$6K ﹤0.01%
291
– –
WFC.PRT
2161
DELISTED
WELLS FARGO & COMPANY SERIES T
WFC.PRT
$6K ﹤0.01%
250
– –
OPB
2162
DELISTED
Opus Bank Common Stock
OPB
$6K ﹤0.01%
260
+130
+100% +$3.22K
PEGI
2163
DELISTED
Pattern Energy Group Inc. Class A
PEGI
$6K ﹤0.01%
255
– –
AKS
2164
DELISTED
AK Steel Holding Corp
AKS
$6K ﹤0.01%
2,027
– –
KKR.PRA
2165
DELISTED
KKR & Co. Inc. 6.75% Series A Preferred Units
KKR.PRA
$6K ﹤0.01%
250
– –
TERP
2166
DELISTED
TerraForm Power, Inc
TERP
$6K ﹤0.01%
430
– –
EMAG
2167
DELISTED
VanEck Vectors Emerging Markets Aggregate Bond ETF
EMAG
$6K ﹤0.01%
+300
New +$6.48K
AWC
2168
DELISTED
Alumina Ltd
AWC
$6K ﹤0.01%
1,066
-208
-16% -$1.17K
REGI
2169
DELISTED
Renewable Energy Group, Inc.
REGI
$6K ﹤0.01%
256
– –
MBT
2170
DELISTED
Mobile TeleSystems Public Joint Stock Company American Depositary Shares (Each representing 2 Shares
MBT
$6K ﹤0.01%
630
-1,000
-61% -$9.15K
WLH
2171
DELISTED
WILLIAM LYON HOMES
WLH
$6K ﹤0.01%
331
-44
-12% -$899
ACLS icon
2172
Axcelis
ACLS
$3.69B
$5K ﹤0.01%
239
-88
-27% -$1.85K
ANIP icon
2173
ANI Pharmaceuticals
ANIP
$1.84B
$5K ﹤0.01%
95
+29
+44% +$1.92K
BC icon
2174
Brunswick
BC
$5.33B
$5K ﹤0.01%
100
– –
BKE icon
2175
Buckle
BKE
$2.35B
$5K ﹤0.01%
202
– –
85 86
87
88 89

Similar funds

SLAM
Swiss Life Asset Management Zurich $20.4B AUM 28.71% 1-Year Est. Return
EWA
EP Wealth Advisors Torrance, California $20.3B AUM
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return
P
&Partners Nashville, Tennessee $20.2B AUM 19.79% 1-Year Est. Return
CI Investments Inc
CI Investments Inc Toronto, Ontario, Canada $20.6B AUM 29.22% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return

Glenmede Trust's Q4 2019 Portfolio in Review

As of Q4 2019, Glenmede Trust held 3,337 positions worth $21.9B, up 100,205% from $21.9M the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Glenmede Trust's Q4 2019 filing shows 135 new, 1,103 increased, 1,007 reduced and 163 closed positions. Its largest new stake was Callon Petroleum Company: 285,674 shares worth $13.8M. The largest sale was Celanese, an estimated $108M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

  • Glenmede Trust's largest Q4 2019 buy was Callon Petroleum Company: 285,674 shares worth $13.8M.
  • Glenmede Trust added most to Bristol-Myers Squibb in Q4 2019, an estimated $89.3M increase.
  • Glenmede Trust's biggest Q4 2019 reduction was Celanese, cutting an estimated $108M.
  • Glenmede Trust fully exited Celgene Corp in Q4 2019, selling an estimated $122K.
  • Glenmede Trust's ten largest holdings make up 13% of its $21.9B portfolio in Q4 2019.
  • Glenmede Trust opened 135 new positions and closed 163 in Q4 2019.
  • Glenmede Trust's portfolio value rose 100,205% quarter-over-quarter to $21.9B.

Based on Glenmede Trust's 13F filing for Q4 2019, filed 12 Feb 2020.